Evidence map›Paper›PMID 29410835›Full record

ArticleRoyal Society open science2018

Yang-Liu Xia, Tong-Yi Dou, Yong Liu, Ping Wang, Guang-Bo Ge, Ling Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Royal Society open science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Analytical methodologies for sensing catechol-Journal of pharmaceutical analysis · 2021
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yang-Liu XiaLaboratory of Pharmacology & Toxicology, School of Life Science and Medicine, Dalian University of Technology, Panjin 124221, People's Republic of China.ORCID 0000-0002-5742-7182
Tong-Yi DouLaboratory of Pharmacology & Toxicology, School of Life Science and Medicine, Dalian University of Technology, Panjin 124221, People's Republic of China.
Yong LiuLaboratory of Pharmacology & Toxicology, School of Life Science and Medicine, Dalian University of Technology, Panjin 124221, People's Republic of China.
Ping WangInstitute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicines, Shanghai 201203, People's Republic of China.
Guang-Bo GeInstitute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicines, Shanghai 201203, People's Republic of China.
Ling YangInstitute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicines, Shanghai 201203, People's Republic of China.
Dalian University of Technology · CNShanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Daphnetin (7,8-dihydroxycoumarin (7,8-DHC)) and its C-4 derivatives have multiple pharmacological activities, but the poor metabolic stability of these catechols has severely restricted their application in the clinic. Methylation plays important roles in catechol elimination, although thus far the effects of structural modifications on the metabolic selectivity and the catalytic efficacy of human catechol-

Indexed as

78-dihydroxycoumarinshuman catechol-O-methyltransferasemetabolic stabilitystructure–methylation relationship

Identifiers

PMID29410835
PMCPMC5792912
OpenAlexW2782573843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.